Posttraumatic stress disorder and breast cancer: Risk factors and the role of inflammation and endocrine function
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
A breast cancer diagnosis can be a life‐changing and stressful experience that can lead to chronic mental health conditions such as posttraumatic stress disorder (PTSD). Greater than one‐third of patients initially diagnosed with PTSD after a diagnosis of breast cancer continue to have persistent or worsening PTSD symptoms after 4 years. An emerging body of literature has indicated several key environmental and biological risk factors for PTSD among survivors of breast cancer. Well‐recognized risk factors include having a history of childhood trauma, being nonwhite, obesity, younger age at the time of diagnosis, diagnosis with a higher stage of breast cancer, and short time since treatment. Of the emerging risk factors related to fear circuitry in the brain, 2 pathways of particular importance are the stress‐driven activation of inflammatory pathways and the long‐term effect of antiendocrine therapies. These central and peripheral responses during and after stress exposure are important because increased fear and anxiety can lead to the maintenance of PTSD and worse patient outcomes. Given the poor outcomes associated with PTSD and the high prevalence of breast cancer in women, more research to identify those women at heightened risk of PTSD after breast cancer is warranted to reduce the number of diagnoses and lessen the negative impact of this chronic mental health condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“”(54) The negative effect of inflammation on mental health also extends beyond PTSD, because increased inflammatory biomarkers also have been found in individuals with depression as well as fear-based and anxiety-based disorders such as generalized anxiety disorder and panic disorder.(54,55)”
BackgroundSelf-citationCancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008
The effects of childhood maltreatment on brain structure, function and connectivity
Teicher, M. H., Samson, J. A., Anderson, C. M., & Ohashi, K. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.111 · Cited by 1,856
LeDoux, J. (2007) · Current Biology · doi:10.1016/j.cub.2007.08.005 · Cited by 1,281
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217
The sympathetic nervous system induces a metastatic switch in primary breast cancer
Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., Arevalo, J. M. G., Morizono, K., Karanikolas, B. D. W., Wu, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0522 · Cited by 930
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.146 · Cited by 786 · cited 2×
“”(54) The negative effect of inflammation on mental health also extends beyond PTSD, because increased inflammatory biomarkers also have been found in individuals with depression as well as fear-based and anxiety-based disorders such as generalized anxiety disorder and panic disorder.(54,55)”
BackgroundPassos, I. C., Vasconcelos-Moreno, M. P., Costa, L. G., Kunz, M., Brietzke, E., Quevedo, J., Salum, G., Magalhães, P. V., Kapczinski, F., & Kauer-Sant'Anna, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00309-0 · Cited by 743 · cited 1×
“In the case of PTSD, it has been found that individuals with PTSD tend to have higher levels of proinflammatory mediators including TNF-α, IL-1b, and IL-6 compared with healthy controls in addition to having decreased anti-inflammatory markers.(53,54) One mechanism by which inflammation may contribute to PTSD is throu…”
BackgroundNievergelt, C. M., Maihofer, A. X., Klengel, T., Atkinson, E. G., Chen, C.-Y., Choi, K. W., Coleman, J. R. I., Dalvie, S., Duncan, L. E., Gelernter, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12576-w · Cited by 635 · cited 2×
“Another large GWAS of PTSD cases versus controls was conducted by the Psychiatric Genomics Consortium Posttraumatic Stress Disorder Working Group, which combined a diverse international group representing both civilian and military trauma in >60 cohorts.(95) This study identified a different set of risk loci for PTSD…”
BackgroundMethodSelf-citationIncidence of Suicide in Persons With Cancer
Misono, S., Weiss, N. S., Fann, J. R., Redman, M., & Yueh, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8941 · Cited by 608
The functional neuroanatomy of PTSD: a critical review
Liberzon, I., & Sripada, C. S. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)67011-3 · Cited by 594
Major depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
Sympathetic nervous system regulation of the tumour microenvironment
Cole, S. W., Nagaraja, A. S., Lutgendorf, S. K., Green, P. A., & Sood, A. K. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3978 · Cited by 576 · cited 1×
“table finding is that activation of the SNS regulates breast cancer metastasis through β-adrenergic signaling, and it is hypothesized that blocking SNS activity may minimize breast cancer metastasis, an effect that may be mediated by SNS effects on the inflammatory response.(57,58)”
BackgroundThe key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
Labrie, F., Luu-The, V., Lin, S.-X., Claude, L., Simard, J., Breton, R., & Bélanger, A. (1997) · Steroids · doi:10.1016/s0039-128x(96)00174-2 · Cited by 480
Vickberg, S. M. J. (2003) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm2501_03 · Cited by 468
The sympathetic nervous response in inflammation
Pongratz, G., & Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0504-2 · Cited by 427 · cited 1×
“When the sympathetic nervous system (SNS) is activated during stress, one of its effects is to stimulate inflammatory pathways.(44,45) Maintaining a proinflammatory state over time can contribute to a decline in physical health across several systems.”
BackgroundDuncan, L. E., Ratanatharathorn, A., Aiello, A. E., Almli, L. M., Amstadter, A. B., Ashley-Koch, A. E., Baker, D. G., Beckham, J. C., Bierut, L. J., Bisson, J., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.77 · Cited by 425
Mehnert, A., & Koch, U. (2007) · Psycho-Oncology · doi:10.1002/pon.1057 · Cited by 402
Obesity and mental disorders in the adult general population
Scott, K. M., McGee, M. A., Wells, J. E., & Oakley Browne, M. A. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.09.006 · Cited by 393
Fear of cancer progression and cancer‐related intrusive cognitions in breast cancer survivors
Mehnert, A., Berg, P., Henrich, G., & Herschbach, P. (2009) · Psycho-Oncology · doi:10.1002/pon.1481 · Cited by 354
Marmar, C. R., Schlenger, W., Henn-Haase, C., Qian, M., Purchia, E., Li, M., Corry, N., Williams, C. S., Ho, C.-L., Horesh, D., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0803 · Cited by 322
Breast cancer as trauma: posttraumatic stress and posttraumatic growth
Cordova, M. J., Giese-Davis, J., Golant, M., Kronenwetter, C., Chang, V., & Spiegel, D. (2007) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-007-9083-6 · Cited by 305 · cited 1×
“However, for the majority of women, a breast cancer diagnosis is sudden, necessitates a catastrophic disruption in their life course, and bears the potential threat of death.(10) For the purposes of this review, we have considered breast cancer diagnosis and treatment to be stressful events that meet PTSD criterion A(…”
BackgroundAbbey, G., Thompson, S. B. N., Hickish, T., & Heathcote, D. (2015) · Psycho-Oncology · doi:10.1002/pon.3654 · Cited by 280
Fear of cancer recurrence: specific profiles and nature of intrusive thoughts
Simard, S., Savard, J., & Ivers, H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0136-8 · Cited by 229
Jonas, D. E., Cusack, K., Forneris, C., Wilkins, T. M., Sonis, J., Middleton, J. C., Feltner, C., Meredith, D., Cavanaugh, J., Brownley, K. A., et al. (2013) · PsycEXTRA Dataset · doi:10.1037/e553842013-001 · Cited by 178
Stevens, J. S., Kim, Y. J., Galatzer-Levy, I. R., Reddy, R., Ely, T. D., Nemeroff, C. B., Hudak, L. A., Jovanovic, T., Rothbaum, B. O., & Ressler, K. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.11.015 · Cited by 177
Self-citationvan Rooij, S. J. H., Kennis, M., Vink, M., & Geuze, E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.257 · Cited by 122 · cited 1×
“The amygdala is a region of the brain involved in regulating several emotion-related functions,(84) and hyperreactivity of the amygdala in response to threat stimuli has been associated with PTSD symptom formation and maintenance,(85,86) as well as treatment resistance.(87) Antiendocrine therapies may disrupt the typi…”
BackgroundArnaboldi, P., Riva, S., Crico, C., & Pravettoni, G. (2017) · Breast Cancer: Targets and Therapy · doi:10.2147/bctt.s111101 · Cited by 98 · cited 3×
“3%.(9) Although this range may reflect variability in the experience of a breast cancer diagnosis as a criterion A stressor, it also suggests that additional factors may contribute to a patient’s risk of developing PTSD after a diagnosis of breast cancer.”
BackgroundInfluentialCancer and post-traumatic stress disorder: Diagnosis, pathogenesis and treatment considerations
Rustad, J. K., David, D., & Currier, M. B. (2012) · Palliative and Supportive Care · doi:10.1017/s1478951511000897 · Cited by 48 · cited 1×
“of both cancer and PTSD, and therefore serves as a physiological link by which one condition may exacerbate the other.(47) Inflammation has been shown to promote the”
BackgroundTamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery
Miranda, J., & Colón, J. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.189164 · Cited by 35
Cited by
Cancer and stress: NextGen strategies
Cui, B., Peng, F., Lu, J., He, B., Su, Q., Luo, H., Deng, Z., Jiang, T., Su, K., Huang, Y., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.005 · Cited by 152
Psychological Aspects of Breast Cancer
Penberthy, J. K., Stewart, A. L., Centeno, C. F., & Penberthy, D. R. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.04.010 · Cited by 48
Zhang, X., Sun, D., Wang, Z., & Qin, N. (2022) · Current Oncology · doi:10.3390/curroncol29120746 · Cited by 23
Metadata
- Authors
- Brown, L. C., Murphy, A. R., Lalonde, C. S., Subhedar, P. D., Miller, A. H., & Stevens, J. S.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2020-05-06
- Volume
- 126
- Issue
- 14
- Pages
- 3181-3191
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W3020987512
- Cited by
- 68
- References
- 31
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.